Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (10) , 1474-1478
- https://doi.org/10.1016/0959-8049(94)00253-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.Journal of Clinical Oncology, 1992
- Epirubicin in previously untreated patients with small cell lung cancer: A phase II study by the EORTC lung cancer cooperative groupEuropean Journal Of Cancer, 1992
- High dose etoposide for brain metastases of small cell lung cancer. A phase II studyBritish Journal of Cancer, 1989
- Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small-cell lung cancerCancer Chemotherapy and Pharmacology, 1989
- Cisplatin and Etoposide as Second-Line Chemotherapy in Patients with Small Cell Lung CancerCancer Investigation, 1988
- Superiority of Alternating Non-Cross-Resistant Chemotherapy in Extensive Small Cell Lung CancerAnnals of Internal Medicine, 1987
- VP-16 and cisplatin as first-line therapy for small-cell lung cancer.Journal of Clinical Oncology, 1985
- Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.Journal of Clinical Oncology, 1984
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958